Cattral, M. S.

Dr. Mark S. Cattral

Division of General Surgery
Toronto General Hospital
585 University Avenue, Room 11NCSB-1232 
Norman Urquart Wing
Toronto, ON
M5G 2N2

Tel: 416 340-3760
Fax: 416 340-4039
Email: Mark.Cattral@uhn.ca

Dr. M. Cattral 

Director of Pancreas Transplantation Program



Dr. Mark Cattral is a Professor of Surgery, the Director of the Pancreas Transplantation Program, and a scientist at the University Health Network, University of Toronto. He has played a key role in the development of the adult live donor liver transplant program at the University Health Network, which is now the largest in North America. Dr. Cattral’s laboratory is investigating dendritic cell biology and strategies to induce transplantation tolerance. Recent discoveries from his laboratory have contributed to the current understanding of dendritic cell ontogeny and function of immediate dendritic cell precursors.


   



Clinical Interest:
Kidney/Pancreas/Liver Transplantation, Hepatobiliary Surgery

Research Activities:
Transplantation, Tolerance Induction

Recent Publications:
1. Cattral MS, Hemming AW, Wanless I, Ashgar H, Krajden M, Lilly LB, Greig PD, Levy GA: Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation. Transplantation 1999: 67: pp 1277-1280.

2. Bigam D, Hemming AW, Sanabria JR, Cattral MS: Innominate artery interposition graft simplifies the portal venous drainage method of pancreas transplantation. Transplantation 1999: 68: pp 314-315.

3. Gorczynski RM, Cattral MS, Chen Z, Hu J. Lei J, Min WP, Yu G, Ni J; An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant which prolongs allo-and xenograft survival. Journal of Immunology 1999: 163: pp 1654-1660.

www.ncbi.nlm.nih.gov/PubMed/